Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hiromi, Shintani"'
Autor:
Toshihisa, Nakashima, Takayoshi, Kiba, Yoshikazu, Ogawa, Atsuko, Hosokawa, Hiromi, Shintani, Yuuko, Okada, Takako, Taniguchi, Masanobu, Shigeta, Kazuhiro, Kozawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(9)
Were port a 51-year-old male left renal pelvic cancer patient with paclitaxel (PTX)-induced peripheral neuropathy, which was successfully treated with pregabalin. From June 2010, a gemcitabine/PTX (GP) regimen was used as third-line treatment. In ord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fb812c56ea6e4e92eb1858ec5acbafa9
https://pubmed.ncbi.nlm.nih.gov/22996788
https://pubmed.ncbi.nlm.nih.gov/22996788
Autor:
Toshihisa, Nakashima, Takayoshi, Kiba, Yoshikazu, Ogawa, Akiko, Kimura, Miki, Kido, Yoshiko, Okikawa, Takuo, Ito, Akihisa, Saito, Atsuko, Hosokawa, Hiromi, Shintani, Yuko, Okada, Takako, Taniguchi, Kiyomi, Taniyama, Kazuhiro, Kozawa, Hiromasa, Niimi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 39(5)
When performing R-CHOP(rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone)for diffuse large B-cell lymphoma(DLBCL), neurotoxicity of vincristine(VCR)is the serious dose-limiting factor.Pregabalin is one of the first-line treatments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d9094c9b2f76ce96bb0f49d9ab8dc0d4
https://pubmed.ncbi.nlm.nih.gov/22584337
https://pubmed.ncbi.nlm.nih.gov/22584337